3-rx.comCustomer Support3-rx.com
Find a product
    HomeAbout UsFAQContactHelp
 
   
 
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics
Online Pharmacy



Alternate Names : Dysmenorrhea. Menstrual cramps are the pain and cramping some women experience during their monthly periods. The term dysmenorrhea usually refers to pain and cramps severe enough to prevent normal activity


Join our Mailing List

Men`s Health sites at Top100biz.com




Syndicate

You are here : 3-RX.com > Home > Fertility and pregnancy - Pregnancy -

Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects

Fertility and pregnancy • • PregnancyJul 02, 07

Information regarding the safety of selective serotonin-reuptake inhibitors (SSRIs) in human Pregnancy is sparse. Concern has been raised about the risk of congenital heart defects associated with the use of SSRIs in Pregnancy.

Methods We obtained data on 9622 case infants with major birth defects and 4092 control infants born from 1997 through 2002 from the National Birth Defects Prevention Study. Case infants were ascertained through birth-defects surveillance systems in eight U.S. states; controls were selected randomly from the same geographic areas. Mothers completed a standardized telephone interview regarding exposure to potential risk factors, including medications, before and during Pregnancy. Exposure to SSRIs was defined as treatment with any SSRI from 1 month before to 3 months after conception. Birth defects were assigned to 26 categories and subcategories.

Results There were no significant associations between maternal use of SSRIs overall during early Pregnancy and congenital heart defects or most other categories or subcategories of birth defects. Maternal SSRI use was associated with anencephaly (214 infants, 9 exposed; adjusted odds ratio, 2.4; 95% confidence interval [CI], 1.1 to 5.1), craniosynostosis (432 infants, 24 exposed; adjusted odds ratio, 2.5; 95% CI, 1.5 to 4.0), and omphalocele (181 infants, 11 exposed; adjusted odds ratio, 2.8; 95% CI, 1.3 to 5.7).

Conclusions Maternal use of SSRIs during early Pregnancy was not associated with significantly increased risks of congenital heart defects or of most other categories of birth defects. Associations were observed between SSRI use and three types of birth defects, but the absolute risks were small, and these observations require confirmation by other studies.


Sura Alwan, M.Sc., Jennita Reefhuis, Ph.D., Sonja A. Rasmussen, M.D., M.S., Richard S. Olney, M.D., M.P.H., Jan M. Friedman, M.D., Ph.D., for the National Birth Defects Prevention Study

Full text



Print Version
Tell-a-Friend

RELATED ARTICLES:
  Even moderate drinking in pregnancy harmful: study
  “Watchful waiting” okay for hernias in pregnancy
  Blood tests may show inherited diseases in fetuses
  Pregnancy study finds strong association between two antidepressants and heart anomalies
  Consent form developed for infertility therapy
  Pregnancy diabetes doubles the risk of language delay in children
  Pregnancy disorder signals need to screen for heart disease, study shows
  Nicotine replacement safe during pregnancy
  Woman in Berlin gives birth to sextuplets
  Early exposure to drugs, alcohol creates lifetime of health risk
  Smoking during pregnancy can put mums and babies at risk
  Infections linked to premature births more common than thought, Stanford study finds

 


Advertisement
















Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site